Marchesi, F <br/><br/>
Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.  [electronic resource] 

 -  Transplant infectious disease : an official journal of the Transplantation Society  Dec 2014 
 - 1032-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1399-3062 
<br/><br/><label>Standard No.: </label>10.1111/tid.12309  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Cytomegalovirus Infections--pathology<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--therapy<br/>Pyrazines--administration & dosage<br/>Retrospective Studies<br/>Risk Factors<br/>Stem Cell Transplantation<br/>Vincristine--administration & dosage